Elevance Health, Inc.

Elevance Health, Inc. (ELV) — Form 144: Proposed sale of shares

144ELVFiled Oct 22, 2026, 4:03 PM ET

AI-generated summary

MARK B KAYE, Officer of Elevance Health, Inc., proposed to sell 10,584 Common shares with an aggregate market value of $4,658,378.26 through Morgan Stanley Smith Barney LLC Executive Financial Services. The approximate sale date is October 22, 2026. The shares to be sold were acquired as restricted stock and performance shares between October 2, 2025, and October 2, 2026.

View original filing on SEC.gov

Key facts

Seller: MARK B KAYE
Relationship: Officer
Shares to sell: 10,584
Market value: $4,658,378.26
Approximate sale date: Oct 22, 2026
Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
Acquired (1): Oct 2, 2025 · Restricted Stock
Acquired (2): Oct 2, 2025 · Restricted Stock
Acquired (3): Mar 1, 2026 · Restricted Stock
Acquired (4): Mar 3, 2026 · Restricted Stock
Acquired (5): Oct 2, 2026 · Restricted Stock
Acquired (6): Oct 2, 2026 · Performance Shares
Acquired (7): Oct 2, 2026 · Restricted Stock

More ELV filings

S-3ASR
SEC filing
Filed Oct 28, 2026
4
Insider transaction
Filed Oct 23, 2026
10-Q
Quarterly report
Filed Oct 21, 2026
8-K
Current report
Filed Oct 21, 2026
4
Insider transaction
Filed Oct 6, 2026
8-K
Current report
Filed Sep 10, 2026

Not investment advice. Summaries can contain errors; the SEC filing is the official record.